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Cox Swvival Eatimalea
SDNN ASDNN5 SDANN5
50 ma 150 ma 20 ma 60 ma 40 ms 140 ma
1 yr 0.92 0.97 0.90 0.98 0.92 0.97
2 yrs 0.80 0.93 0.77 0.95 0.81 0.93
to2.4fold increase in risk.Thus, in chronic coronary disease decreased HRV
should be considered an important marker for increased long-term mortality
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m7316 The Effect of Beta-Blockers on Recovery of HeartRate Variability in the Beta Blocker Hesrt Attack Trial
(BHAT)
R.J. Lampert, J.R. Ickovics, C.M. Viscoli, L.E. Rosepfeld, R.1.Horwitz,
F.A. Lee. Yale School of Medicine, New Haven, CT USA
Heart rate variability(HRV), a predictor of post-Ml mortality, is depressed
immediately poet-Ml and recovers partially over time. To evaluate the effect
of beta blocker (BB) on recovery of HRV post-Ml, we analyzed HRV parem-
etem from 24-hour Holters recorded one week post-Ml and 6 weeks later
in 68 propanolol- and 98 placebc-treated male BHAT study pts (age 53.8 +
9.1). Baseline frequency domain HRV parameters (log-transformed) did not
differ betweengroups. High frequency (HF) power, an index of vagal tone,
increased more over 6 weeks in BB compared to placebo group: 4,28+0.08
to 5.17 * 0.08 in BB vs 4.25 + 0.08 to 4.78 & 0.08 in placebo, p <0.05.
Sympetho-vagal balance measured by the low frequency (LF) to HF ratio
increased in placebo pte (1.03 + 0.05 to 1.17 + 0.05) but decreased in the
BB group (1.09 + 0.05 to 0.96 + 0.05), a significant difference (p < 0.01).
The increase over 6 weeks in ultra low, very low, LF,and total power was not
affected by BB. At 6 weeks, the morning increase in LF/HF was blunted by
BB (p < 0.05).
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In post-Ml pts, BB therapy significantly improves fi?coveryof parasym-
pathetic tone and alters sympatho-vagal balance, particularly on awakening.
These findings may elucidate mechanisms by which BBs decrease mortality
and reduce tire early morning risk of sudden death prst-Ml.
n732 Newer Therapyfor AtrialFibrillation
Tuesday, March 18, 1997, 8:30 a.m.–l O:OOa.m.
Anaheim Convention Center, Room B1
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El7321 Biatrial Linear and Focal Ablation For ReetoringSinua Rhythm [n Patiente With Refractory Atrial
Fibrillation: Initial Experience With A Two Staged
Prooedure
J.D. Maloney, V. Chodimella, A. Sabe, F.O. Mkparu, L. Milner, M.L. Markel,
Ohio Heart Care, 4455 Dreasler RoadrVw, Canton, OH, USA
Radiofrequency catheter ablation (RFCA) has gained wide acceptance as a
therepyformost atrial tachyarrhythmias with the excluaionof atrial fibrillation.
Initial RFCAexperience suggeatathat extensive anatomic-electrophysiologic
substrate (AES) modification of both atria can be an antidote for refractory
chronic atrial fibrillation (CAF): but residual atrial tachycardias have been
frequent. Therefore a two staged biatrial linear and focal ablation (BALF) pro-
cedure was designed to address previous limitations including excessively
prolonged procedures and high morbidity. A two staged BALF procedure for
8 patients (pts) was pertormed to cure CAF with and without structural heart
disease. A total of 14 BALF-CAF procedures were performed averaging 5
hours and 100 lesions per procedure. Left atrial accees was obtained by
transseptal Brockenbraugh needle in 5/8 pts and 7/14 procedures. Observa-
tions and Results: Left atrial linear lesions were generally followed by more
organized and focal tachycardias, most commonly identified around the pul-
monary vein os and left atrial appendage. Sudden reversion to sinus rhythm
occurs with additional focal RFCA. Recurrence of tachycardias prior to stage
2 is commonly focal and atypical for CAF. Stage 2 always included focal
RFCA plus repeated linear lesions. No thromboembolic complications were
obsetved. Normal sinua rhythm was reatored in all patients transiently, main-
tained in 5/6 pts that underwent stage 2, with mean follow-up of 3 months.
Atrial funtiion as measured by atrial contflbution to mitral valve inflow, as
well as atrial dimension appears to have improved over an average period of
2 months following BALF.
Conckrsions:1). A two staged BALFcan modi~ AES in pts with CAFwith
restoration of sinus rhythm and limited morbidity. 2). Repeat left atrial access
is usually achievable without use of Brockenbraugh needle if performed
within 6 weeks. 3). The change in atrial tachycardia morphology with multiple
lesions may provide inaights into mechanisms of CAF. 4). BALF appears to
restore and maintain sinus rhythm in selected patients.
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1732-21Atrial MaPPin9and Effectiveneasof aRi9ht Atria,
Cathater Ablation in Patients with Vagal Atrial
Fibrillation
F.Gaita, R. Riccardi, M. Scaglione, F. Lemberti, E. Richiardi, L. Calb,
L. Garberoglio, R. Maasa, M. Bocchiardo, S. MiceIi. Division of Cardio/og~
Hospita/ of Asti, /fa/y
Experimental evidences suggested that in patients (pte) with vagal (V) atrial
fibrillation (AF) the right atrium (A) is generally primarily involved in the
maintenance of the AF. Aim of this work was to evaluate the efficacy and
safety of a new procedure of CA for V AF with a right atrial approach.
Fourteen consecutive pts (mean age 52,*10 yeare) with V AF, all highly
symptomatic for palpitations and refracto~ to all antiarrhythmic druga, un-
derwent RF CA. Nine pts had daily sustained paroxysmal AF and 5 had
persistent AF. In all the pts mapping of both right A, using special multieleo-
trode catheters, for a total of 40 electrodes, and left was performed. Three
anatomic lesions were performed in the right A: a) from the superior vena
cava (VC) to the fossa ovalis and from this to the inferior VC; b) in the infe-
rior VC-tricuspid annqlus isthmus and c) a transversal lesion from the fossa
ovalis to the lateral edge of the tricuspid annulus. Special catheters with multi
4 mm electrodes. Success of the ablation was considered if no recurrences
of AF occurred either without or with previously ineffective drugs.
In 9 pts atrial mapping showed a regular rapid atrial activity in the lateral
rightAwhile it was irregular,and fragmented in the septal region. In5 pts sinus
rhythm was restored during RF delivery preceded by a gradual organization
of the atrial activity and in 1 at the end of the procedure. No complications
occurred in any pt.
In the follow-up (range 4-16 months) 6 pts did not have AF recurrences (3
treated with previously ineffective drug therapy). Five pts had AF recurrences
and 3 had atrial flutter. Four of the latter 6 were aaymptomatic for palpitations,
although no differences of the heart rate was observed before and after the
ablation.
In conclusion ablation of V AF with a right atrial procedure is possible,
showing that in aome pts the right A is primary involved in the genesisof this
arrhythmia.
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1732-31 RadiofreWencYCatheter Ab,ationoftheRi9ht
Atrium for Control of Atrial Fibrillation Refractory to
Antiarrhythmic Druga
G. FeId, U. Birgersdotter-Green, 0. Fijumura, K. Undesser. University of
California, San Diego, CA, USA
/ntroduction:The Mezeoperation cencureatrialfibrillation (AF).Therefore, we
postulated that long Iinearradiofrequency catheter ablation (RFCA) leaions in
therightatrium (RA), combined with tricuspid valve-inferior venacevaiathmus
(TV-WC) ablation would also modify the substrate for AF, and either prevent
its recurrence or make it easier to control with antiarrhythmic drugs (AAD).
Methods: Vertical linear RFCA of the posterior, septal, and anterior RA and
